UNSPSC 51282945: Temafloxacin

This classification denotes a quinolone antibiotic with the molecular formula C21H18F3N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1WZ12GTT67, chemically known as 3-quinolinecarboxylic acid, 1,4-dihydro-1-(2,4-difluorophenyl)-6-fluoro-7- (3-methyl-1-piperazinyl)-4-oxo- but generally known as temafloxacin, which bears US NIH Compound Identifier 60021. European Medicines Agency schedules Temafloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10877MIG.

UNSPSC 51282945 Temafloxacin is a Commodity code that covers pharmaceutical products, though recent state and local solicitations tagged under this code predominantly involve naloxone, safe drug deactivation systems, generic multi-source pharmaceuticals, over-the-counter products, and direct-to-manufacturer prescription fulfillment arrangements rather than temafloxacin specifically. State and local governments are buying emergency medical supplies, pharmacy benefit management services, and pharmaceutical inventory through cooperative purchasing alliances and individual jurisdiction procurement. Issuing bodies span county health departments, municipal fire and rescue services, state health and human services commissions, and multistate purchasing cooperatives. The Seminole County, Florida IFB for naloxone and drug deactivation systems exemplifies direct municipal procurement for community health initiatives, while the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic pharmaceuticals and OTC products demonstrates state-level aggregated purchasing across multiple jurisdictions and authorized wholesalers, creating opportunities for manufacturers and distributors to supply multiple government end-users simultaneously.

Recent activity concentrates in Florida and Minnesota, with Texas state health agencies conducting preliminary market research through RFI mechanisms. The Seminole County naloxone procurement (IFB 60459723LAS, due July 26, 2023) seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building, awarded on a fixed-fee basis to the lowest responsive bidder. The City of Tampa Fire Department Rescue Division IFB for medical and first aid supplies (26P00145, due March 13, 2026) encompasses 169 line items with an estimated contract value of $700,000.00, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount not to exceed $10,000. The Minnesota MMCAP RFP (S1070000015802, due March 26, 2026) establishes multiple contracts for generic pharmaceuticals and OTC products distributed through three authorized wholesalers with a July 1, 2026 effective date, requiring vendor compliance with cGMP, DSCSA, and a 3 percent administrative fee structure. The Texas Health and Human Services Commission RFI (HHS0017013, response deadline April 3, 2026) solicits vendor capabilities regarding direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements.